A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system

First identified as the etiological agent behind Acquired Immunodeficiency Syndrome (AIDS) in the early 1980s, HIV-1 has continued to spread into a global pandemic and major public health concern. Despite the success of antiretroviral therapy at reducing HIV-1 viremia and preventing the dramatic CD4...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:NPJ Vaccines
Autori principali: Pankrac, Joshua, Klein, Katja, McKay, Paul F., King, Deborah F. L., Bain, Katie, Knapp, Jason, Biru, Tsigereda, Wijewardhana, Chanuka N., Pawa, Rahul, Canaday, David H., Gao, Yong, Fidler, Sarah, Shattock, Robin J., Arts, Eric J., Mann, Jamie F. S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5775397/
https://ncbi.nlm.nih.gov/pubmed/29367885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-017-0040-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi